IPRIPR2022-00257Final Written Decision
Celltrion, Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 9669069.
Type
IPR
Filed
Dec 9, 2021
Instituted
Feb 9, 2022
Decided
Jul 19, 2024
Patent
Application
14972560
Inventor
George D. YANCOPOULOS
Granted
Jun 6, 2017
01
Timeline
3 milestones
2021-12-09Petition filed
2022-02-09Institution
2022-11-09Terminated
02
Parties & counsel
Petitioner
Celltrion, Inc. et al.
Counsel
Green, Loraet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →